GC-FP: Pilot Controlled Trial of Game Changers for Family Planning Peer Advocacy Program

Sponsor
RAND (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06048328
Collaborator
Makerere University (Other)
160
2
7

Study Details

Study Description

Brief Summary

This study will adapt the Game Changers peer advocacy training model for family planning context and pilot test the feasibility, acceptability and preliminary efficacy of the intervention to empower female contraception users to advocate for contraception use among women in their social networks who have unmet need for contraception.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Game Changers for Family Planning
Phase 1/Phase 2

Detailed Description

we will conduct a pilot RCT of Game Changers for Family Planning (GC-FP) with 40 female modern contraceptive (MC) users (index participants) at one rural public clinic, with 20 randomly assigned to receive the intervention (in 2 groups of 10) and 20 to the wait-list control; enrollment and randomization will be stratified by age and relationship status. Each index will recruit up to 3 social network members (alters) with unmet need for MC (max. total=120). Data will be collected at baseline and month 6 from all participants; primary outcome is alter MC use at month 6.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
parallel randomized controlled trial, with individual randomization to receive the intervention or wait-list controlparallel randomized controlled trial, with individual randomization to receive the intervention or wait-list control
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Pilot of a Peer Advocacy Training Intervention to Reduce Unmet Need for Contraception in Uganda
Anticipated Study Start Date :
Apr 2, 2025
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

peer-led, multi-session advocacy training group intervention

Behavioral: Game Changers for Family Planning
Game Changers for Family Planning (GC-FP) intervention. We expect the intervention to consist of 7 group sessions. The sessions will focus on stigma reduction, disclosure decision making, knowledge, and building skills for advocacy. The 2-hour, weekly sessions will be facilitated by 2 trained peers who are MC users, and conducted in Luganda using a structured manual, and group format to facilitate: sharing of experiences to build support, modeling and motivation; group problem solving and role playing to build skills and self-efficacy; and homework between sessions to practice skills and generate experiences to be processed in the group.

No Intervention: Wait-list control

Usual care/no intervention

Outcome Measures

Primary Outcome Measures

  1. Rate of use of modern contraceptives (social network participants) [6 months]

    Proportion of participants who use a modern contraceptive, abstracted from medical chart

Secondary Outcome Measures

  1. Mean level of engagement in family planning advocacy (index participants) [6 months]

    Mean item score on self-report scale measuring engagement in family planning advocacy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Index participants:
Inclusion Criteria:
  • MC user for past year
Social network member participant:
Inclusion Criteria:
  • Not using MC, but reports trying to prevent pregnancy

  • Know about the MC use of their referring index participant

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • RAND
  • Makerere University

Investigators

  • Principal Investigator: Glenn Wagner, RAND

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
RAND
ClinicalTrials.gov Identifier:
NCT06048328
Other Study ID Numbers:
  • 2024-GC-FP
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 21, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by RAND

Study Results

No Results Posted as of Sep 21, 2023